Maintenance Therapy of Duodenal and Gastric Ulcer with H₂-Receptor Antagonists

References

• Boyd E JS, Wilson J A, Wormsley KG. Recurrent ulcer disease. Ranitidine: therapeutic advances, JJ Misiewicz, JR Wood. Excerpta Medica., Amsterdam 1984; 14–42
   Google Scholar
• Boyd E JS, Wilson J A, Wormsley KG. Safety of maintenance treatment of duodenal ulcer with ranitidine. Scand J Gastroenterol 1984; 19: 394–400
   PubMed Web of Science ®Google Scholar
• Walan A, Bianchi Porro G, Hentschel E. Maintenance cimetidine for up to 3 years. Lancet 1985; 1: 115–116
   PubMedGoogle Scholar
• Penston JG, Wormsley KG. Efficacy and safety of long-term maintenance therapy of duodenal ulcers. Scand J Gastroenterol 1989; 24: 1145–1152
   PubMed Web of Science ®Google Scholar
• Penston J G, Wormsley KG. Long-term maintenance treatment of gastric ulcer with ranitidine. Alimentary Pharmacol Ther, in press
   Google Scholar
• Bardhan KD. Anglo-Irish Cimetidine Long-term Study Group. Six years of continuous cimetidine treatment in peptic ulcer disease: efficacy and safety. Alimentary Pharmacol Ther 1988; 2: 395–405
   PubMed Web of Science ®Google Scholar
• Jones D B, Howden C W, Burget D W, Silletti C, Hunt RH. Alteration of H2-receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H-receptor antagonist. Gut 1988; 29: 890–893
   PubMed Web of Science ®Google Scholar
• Elashoff J D, Grossman MI. Trends in hospital admissions and death rates for peptic ulcer in the United States from 1970-1978. Gastroenterology 1980; 78: 280–285
   PubMed Web of Science ®Google Scholar
• Flood C A, Henning GC. Recurrence of gastric ulcer under medical management. Gastroenterology 1950; 16: 57–69
   PubMedGoogle Scholar
• Viskum A. A comparison of the course of the disease among patients with gastric ulcer, duodenal ulcer, and ulcer dyspepsia without ulcer demonstrable by X-ray. Dan Med Bull 1976; 23: 129–145
   PubMed Web of Science ®Google Scholar
• Krag E. Long-term prognosis in medically treated peptic ulcer. A clinical, radiographical and statistical follow-up study. Acta Med Scand 1966; 180: 657–670
   PubMedGoogle Scholar
• Sotgiu G, Pisi E. Aspects cliniques de la pathologie géographique de l'ulcère gastro-duodénale. Schweiz Z Pathol Bakteriol 1959; 21: 260
   Google Scholar
• Fry J. Peptic ulcer: a profile. Br Med J 1964; 2: 809–812
   PubMed Web of Science ®Google Scholar
• Bodemar G, Walan A. Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet 1978; 1: 403–407
   PubMed Web of Science ®Google Scholar
• Elashoff J D, Van Deventer G, Reedy T J, et al. Long-term follow-up of duodenal ulcer patients. J Clin Gastroenterol 1983; 5: 509–515
   PubMed Web of Science ®Google Scholar
• Pulvertaft CN. Comments on the incidence and natural history of gastric and duodenal ulcer. Postgrad Med J 1968; 44: 579–602
   PubMedGoogle Scholar
• Barr G D, Kang J Y, Canalese J, Piper DW. A two-year prospective controlled study of maintenance cimetidine and gastric ulcer. Gastroenterology 1983; 85: 100–104
   PubMed Web of Science ®Google Scholar
• Piper D W, McIntosh J H, Hudson HM. Factors relevant to the prognosis of chronic duodenal ulcer. Digestion 1985; 31: 9–16
   PubMedGoogle Scholar
• Bertschinger PH, Lacher G, Aenishaenslin W., et al. Presenting characteristics of patients with duodenal ulcer and outcome of medical treatment. Digestion 1987; 36: 148–161
   PubMed Web of Science ®Google Scholar
• Somerville K, Faulkner G, Langman M. Nonsteroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; 1: 462–464
   PubMed Web of Science ®Google Scholar
• Morgan A G, Pacsoo C, MacAdam W AF. Comparison between ranitidine and ranitidine plus Caved-S in treatment of gastric ulceration. Gut 1985; 26: 1377–1379
   PubMed Web of Science ®Google Scholar
• Eberle V F, Rettenmaier G. Kumulation von Risikofaktoren der gastroduodenalen Blutung: Schmerz-/Rheumamittel, Alkohol und Ulkusanam-nese. Z Gastroenterol 1985; 23: 107–114
   PubMedGoogle Scholar
• Piper D W, Greig M, Landecker K D, Shinners J, Waller S, Canalese J. Analgesic intake and chronic gastric ulcer. Acute upper gastrointestinal haemorrhage, personality traits and social class. Proc Roy SocMed 1977; 70: 11–15
   PubMedGoogle Scholar
• Collier DStJ, Pain JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985; 26: 359–363
   PubMed Web of Science ®Google Scholar
• Penston J G, Wormsley KG. Ranitidine maintenance treatment of non-steroidal anti-inflammatory drug-induced duodenal ulceration. Alimentary Pharmacol Ther 1989; 3: 499–503
   PubMedGoogle Scholar
• SontagSGraham D Y, Belsito A, et al. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med 1984; 311: 689–693
   PubMedGoogle Scholar
• Fl Lee, Fielding J D, Holmes G K, et al. Ranitidine: prophylaxis of duodenal ulcer recurrence. Hepato-gastroenterol 1984; 31: 85–87
   PubMedGoogle Scholar
• Rohner HG. Long-term cimetidine for the prevention of recurring peptic ulcer. A multicentre study. Z Gastroenterol 1985; 23: 403–411
   PubMedGoogle Scholar
• Van Deventer G M, Elashoff J D, Reedy T J, Schneidman D, Walsh JH. A randomised study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. N Engl J Med 1989; 320: 1113–1119
   PubMed Web of Science ®Google Scholar
• Morise K, Iizuka A, Inagaki T, et al. Ranitidine in prevention of peptic ulcer relapse - multicentre trial comparing full dose maintenance therapy to reduced dose maintenance therapy. Ther Res 1988; 8: 1147–1158
   Google Scholar
• Boyd E JS, Johnston D A, Wormsley K G, Jenner W N, Salanson X. The effects of cigarette smoking on plasma concentrations of gastric antisecretory drugs. Alimentary Pharmacol Ther 1987; 1: 57–65
   PubMedGoogle Scholar
• Burland W L, Hawkins B W, Beresford F. Cimeti-dine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study. Postgrad Med J 1980; 56: 173–176
   PubMed Web of Science ®Google Scholar
• Texter E C, Navab F. Maintenance therapy of duodenal ulcer with famotidine. Am J Med 1986; 81: 25–32, suppl 4B
   PubMed Web of Science ®Google Scholar
• Boyd E JS, Wilson J A, Wormsley KG. Effects of treatment compliance and overnight gastric secretion on outcome of maintenance therapy of duodenal ulcer with ranitidine. Scand J Gastroenterol 1983; 18: 193–200
   PubMed Web of Science ®Google Scholar
• Boyd E JS, Penston J G, Johnston D A, Wormsley KG. Does maintenance treatment keep duodenal ulcers healed?. Lancet 1988; 1: 1324–1327
   PubMed Web of Science ®Google Scholar
• Elashoff J D, Koch G G, Chi GY. Designing a clinical trial to demonstrate prevention of ulcer recurrence: modelling simulation approaches. Statist Med 1988; 7: 877–888
   PubMedGoogle Scholar
• Boyd E JS, Wilson J A, Wormsley KG. Natural history of asymptomatic recurrences of duodenal ulcer. Scand J Gastroenterol 1984; 19: 808–812
   PubMed Web of Science ®Google Scholar
• Penston J G, Wormsley KG. Outcome of asymptomatic duodenal ulcers during maintenance therapy with ranitidine. Aliment Pharmacol Ther, in press
   Google Scholar